Innovative Respiratory Technology 4DMedical's proprietary XV Technology offers highly visual, four-dimensional lung imaging that reveals detailed regional lung function. This unique solution can significantly enhance diagnostic accuracy for respiratory conditions, creating opportunities to partner with hospitals and clinics seeking advanced lung assessment tools.

Strong Market Validation The recent FDA 510(k) clearance for the revolutionary CT:VQ™ imaging solution, combined with nationwide Medicare reimbursement, positions 4DMedical for rapid adoption across U.S. healthcare providers, opening doors for sales expansion in the U.S. market.

Significant Funding & Expansion With over US$100 million in new funding earmarked specifically to accelerate U.S. expansion and technology dominance, there is a strategic opportunity to engage hospital networks and imaging centers looking to modernize their respiratory diagnostics with cutting-edge software-based solutions.

Targeted Healthcare Partnerships Partnerships with leading academic medical centers such as Stanford, Cleveland Clinic, and UC San Diego demonstrate strong early adoption. Building on these relationships can lead to further collaborations for pilot projects, research grants, and large-scale deployment agreements.

Growing Industry Relevance As respiratory diseases and lung health diagnostics gain importance globally, 4DMedical’s innovative imaging platform aligns well with market trends emphasizing non-invasive, detailed, and rapid lung assessment—making it an attractive solution for hosptials, imaging centers, and health tech integrators.